Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2021
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020
James T Lee, Elisabeth M Hesse, Heather N Paulin, et al.
The Lancet. Rheumatology
|
November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Kristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.
JAMA
|
May 4, 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Osteoarthritis and Cartilage Open
|
December 13, 2024
Study protocol for the PICASSO trial: A randomized placebo-controlled trial to investigate the efficacy and safety of intraarticular steroid injections and an occupational therapy intervention in painful inflammatory carpometacarpal-1 osteoarthritis
Marthe Gløersen, Ingvild Kjeken, A T Tveter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 4, 2022
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Silje W Syversen, Ingrid Jyssum, Anne T Tveter, et al.
The Lancet. Rheumatology
|
January 3, 2022
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
Ingrid Jyssum, Hassen Kared, Trung T Tran, et al.
The Lancet. Rheumatology
|
April 7, 2024
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
The Lancet. Microbe
|
March 3, 2024
Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study
Amanda Ribeiro Dos Santos, Elizabeth Misas, Brian Min, et al.
Nature Medicine
|
June 22, 2021
Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility
Diana M Proctor, Thelma Dangana, D Joseph Sexton, et al.
The Lancet Regional Health. Europe
|
December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Hilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2021
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020
James T Lee, Elisabeth M Hesse, Heather N Paulin, et al.
The Lancet. Rheumatology
|
November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Kristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.
JAMA
|
May 4, 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Osteoarthritis and Cartilage Open
|
December 13, 2024
Study protocol for the PICASSO trial: A randomized placebo-controlled trial to investigate the efficacy and safety of intraarticular steroid injections and an occupational therapy intervention in painful inflammatory carpometacarpal-1 osteoarthritis
Marthe Gløersen, Ingvild Kjeken, A T Tveter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 4, 2022
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Silje W Syversen, Ingrid Jyssum, Anne T Tveter, et al.
The Lancet. Rheumatology
|
January 3, 2022
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
Ingrid Jyssum, Hassen Kared, Trung T Tran, et al.
The Lancet. Rheumatology
|
April 7, 2024
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
The Lancet. Microbe
|
March 3, 2024
Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study
Amanda Ribeiro Dos Santos, Elizabeth Misas, Brian Min, et al.
Nature Medicine
|
June 22, 2021
Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility
Diana M Proctor, Thelma Dangana, D Joseph Sexton, et al.
The Lancet Regional Health. Europe
|
December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Hilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
Page
of 14